Saffron Science

What the depression trials found.

If a low mood has stayed with you, you deserve the studies in ordinary words, not a slogan. In mild to moderate depression, people taking a saffron extract often marked lighter forms than people taking a placebo. In a few small trials the change looked close to an antidepressant. Many of those trials were small, run in one place, and the extracts were not all made the same way. The hope and the caution belong in the same breath.

Threads and a capsule
A thread is food. A capsule is what the trials used. The drawing is not a bottle we sell.

What the studies have found

The forms often came back lighter than on a placebo.

In mild to moderate depression, more than one review found that a saffron extract did more than a placebo. In several trials set beside an SSRI, the easing of symptoms looked similar. Those trials were small. Looking similar is not the same as knowing the two are equal, and the studies were not built to settle that.

A mood form
A picture of the kind of form people filled in. It is not a plot of anyone’s score.

Twelve studies

Ahead of a placebo.

A 2020 review brought together 12 studies of mild to moderate depression. People on saffron came out ahead of people on a placebo. Where the same review looked at synthetic antidepressants, its own summary called saffron as effective as those drugs, and side effects were not clearly different from placebo or from the medicines. The authors still asked for larger, longer trials in more than one center. That request is part of the kindness of the paper. A small good result is not a promise for everyone.

PubMed 32221179

Forty-six trials

The difference had a number, and a lighter score.

A 2024 review gathered 46 randomized trials, from four weeks to forty-eight, across several conditions. Against placebo, the depression effect size was −4.26, with a confidence interval from −5.76 to −2.77. On these forms a negative number means people felt lighter, not heavier. The review called saffron non-inferior to usual medicines. That is the authors’ word for “not worse, in the trials they pooled.” The face-to-face comparisons under that word are fewer, and smaller.

PubMed 38424688

Beck and Hamilton

What people said about themselves moved. The pooled clinician scale did not.

A 2026 review of 34 randomized trials and 1,769 adults found Beck depression scores lower across 14 trials and 817 people, a weighted mean difference of −4.39 (confidence interval −6.64 to −2.15). The Beck form is one a person fills in about their own days. In that same review the Hamilton scale, which a clinician scores, did not show a clear change once the trials were combined. Many single trials had used the Hamilton scale and reported lighter scores. Put together, that signal faded. The reviewers called the certainty moderate, and the trials did not all agree with each other. Both halves matter if you are trying to be honest with yourself.

The 2026 review · PubMed 41693488

Eight studies against an SSRI

No clear gap between the scores.

Short trials, often against fluoxetine or imipramine, looked broadly close over about six weeks. A 2026 review says those trials were small, underpowered, and not designed to prove saffron is as good as the medicine. A separate look at eight depression studies against SSRIs found a standardized difference of 0.10, with a confidence interval from −0.09 to 0.29. That range includes “no difference at all.” People on saffron reported fewer unwanted effects in that comparison, a risk difference of −0.06. Close, in a small trial, is not a reason to set a prescribed medicine down.

PubMed 41939549 · PubMed 38913392

What the trials used

About 28 to 30 milligrams a day.

About 30 milligrams a day of a prepared extract, for about six weeks, is the pattern a 2026 review keeps meeting. A larger 2025 trial used 28 milligrams a day for 12 weeks. Other saffron trials run anywhere from four weeks out to forty-eight, so six or twelve weeks is common, not a rule for every study. These are descriptions of what researchers gave. They are not an amount for you to take from this page.

PubMed 41939549 · PubMed 40414301

A larger, milder trial

Two hundred and two adults, and a large lift on placebo too.

In 2025, 202 adults whose low mood was real but not a full clinical depression took 28 milligrams a day of a standardized extract from the red threads, the one the paper calls Affron, or a placebo, for 12 weeks. On the DASS-21 depression form, scores fell further on the extract, by about 2.92 points (confidence interval −5.13 to −0.71). A drop of 7 points or more happened for 72.3 percent on the extract and 54.3 percent on placebo. The authors said that placebo lift was large, and that it has to be faced, not waved away. Hope itself did a lot of the work. A smaller 2025 trial, 51 healthy adults with a similar mild low mood, used about 30 milligrams a day for six weeks and did not see a clear change on its main mood score. A bigger trial is welcome. It does not mean every mild-mood study agreed.

PubMed 40414301 · PubMed 41047129

Limits worth knowing

Why a hopeful score still asks you to go slowly.

If you are weighing this for yourself, or for someone you love, these are the limits the papers keep returning to. They sit here so the good news does not run ahead of what the studies can hold.

Small trials, and few places.

Many of the early depression trials were small, and a 2026 review describes the settings as narrow. A good few weeks in one clinic is still a real result. It is a tender basis for a promise about the next person who walks in.

The capsules were not all the same capsule.

Some extracts came from the red threads. Some came from the petal. The amount of crocin or safranal printed on a label changes from bottle to bottle. A kind result belongs to the preparation those people swallowed, not to every jar that says saffron.

Kinder results are easier to find in print.

That 2026 review names publication bias, and bias in the studies themselves, as reasons to stay modest. A trial that finds a lift is easier to meet in a journal than a trial that finds quiet. The Beck result was graded moderate, and the trials still scattered widely from one another.

We do not know the long road yet.

About six weeks is the length you will see most often. Twelve weeks appears in the larger mild-mood trial. What happens after that, or if someone stops, is still thinly told. A few trials added an extract for people who had only partly responded to usual care. Those results are early, uneven, and not a reason to add a capsule beside a prescribed medicine without the clinician who knows you.

These limits are the ones named in PubMed 41939549, and in the opening of the larger 2025 trial.

What people actually took

The trials used an extract, not a pinch from the jar.

If you cook with saffron, that pinch is food, and it is lovely food. It is not what these depression trials studied. They used a prepared extract, often from the red threads, weighed in milligrams. A kitchen pinch for four people is about a tenth of a gram. Dividing it does not turn it into 28 or 30 milligrams of extract, and it will not recreate what those volunteers swallowed.

On a label, “standardized” usually means the maker has named the plant part and a stated amount of crocin or safranal. That sentence helps you hold a bottle next to a paper. It is the maker’s promise about the powder, not the paper’s finding about mood. Petal extracts show up in this research too, and a result for the red threads does not cover them.

The parent house stays with that difference, between a thread and a capsule, for as long as you want to sit with it: saffronscience.com.

Milligrams

The trial. Milligrams of extract. About 30 milligrams a day in many depression trials. 20 milligrams a day in the macular trial.

A different quantity

Not the trial. A pile of raw threads. The studies did not use a pile like this, and the drawing invents no weight.

Two different materials, named in the captions. The picture does not invent a gram.

How to read a paper

Six things worth finding before you let a study reassure you.

Randomized. People were assigned by chance, so the two groups started out fair.

A placebo. A lookalike capsule shows how much of the lift was hope itself.

The dose. How many milligrams, and milligrams of what.

The weeks. How long people stayed with it.

The extract. Red threads or petal, and whether crocin or safranal was named.

The measure. Which form, and whether a person filled it in or a clinician did.

You do not have to become a researcher to ask these. The parent house walks through the same questions for sleep, worry, and the eye: how the hub reads a paper.

A last word

A lighter score in a study is not a plan for you.

What you have read is what happened to groups of people in trials. You are one person, with your own history. A kinder score on a form is not a substitute for care, and it is not a reason to set a prescribed medicine down.

The clinicians who write guidelines have not put saffron at the front of the line, and that is worth hearing kindly. The 2024 CANMAT depression guideline lists specific doses of saffron as a third-line complementary option for mild major depression. Third-line means it is not where care starts. An earlier WFSBP and CANMAT taskforce, looking at plant extracts and supplements, did count saffron as having positive evidence in depression, and they marked it below St John’s wort. A 2026 review says the same thing in everyday words: something that may sit beside usual care, sometimes added when depression is moderate, and not the first thing to reach for.

CANMAT 2024 · PubMed 35311615 · PubMed 41939549

Nothing here treats, cures, or stands in for a clinician who knows you. Pregnancy is a reason to skip a supplement. If you already take a medicine for mood, talk with the person who prescribed it before you add an extract, and before you stop anything. The trials used milligrams of extract. A large amount of raw threads is a different exposure, and these studies did not test it.

If you are thinking about harming yourself, please reach a person. In the United States you can call or text 988, or visit 988lifeline.org. You do not have to decide that alone.

If a bottle is ever linked from this house, someone will have opened the Amazon or Walmart page first. A future affiliate program may earn a commission from that visit. None is connected today. There is no product on this page, and no price.